S183: PHASE III RANDOMIZED, MULTICENTER, OPEN-LABEL COMMODORE 1 TRIAL: COMPARISON OF CROVALIMAB VS ECULIZUMAB IN COMPLEMENT INHIBITOR-EXPERIENCED PATIENTS WITH PAROXYSMAL NOCTURNAL...

por Scheinberg, Phillip, Cle, Diego, Edwards, John, Giai, Valentina, Hus, Marek, Kim, Jin Seok, Lekue, Cristina Barrenetxea, Nagy, Zsolt, Nur, Erfan, Panse, Jens, Ueda, Yasutaka, Yenerel, Mustafa Nuri, Appius, Anita, Balachandran, Nadiesh, Chebon, Sammy, Gentile, Brittany, Buatois, Simon, Kulasekararaj, Austin
Publicado 2023